These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22263621)

  • 1. The use of dopaminergic and stimulant drugs for the treatment of depression.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Feb; 50(2):11-4. PubMed ID: 22263621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a role for psychostimulants in old age depression and apathy?
    Ng B
    Int Psychogeriatr; 2009 Apr; 21(2):417-8. PubMed ID: 19216822
    [No Abstract]   [Full Text] [Related]  

  • 3. [Basics of the drug therapy for attention deficit hyperactivity disorders in adolescents].
    Airaksinen E; Airaksinen MM
    Duodecim; 2003; 119(16):1553-62. PubMed ID: 14535028
    [No Abstract]   [Full Text] [Related]  

  • 4. [New therapeutic options in the treatment of attention deficit/hyperactivity disorder].
    Artigas Pallares J
    Rev Neurol; 2004 Feb; 38 Suppl 1():S117-23. PubMed ID: 15011165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs under investigation for attention-deficit hyperactivity disorder.
    Schweitzer JB; Holcomb HH
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1207-11. PubMed ID: 12211416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stimulant and non-stimulant medication in current and future therapy for ADHD].
    Franke AG; Konrad A; Lieb K; Huss M
    Fortschr Neurol Psychiatr; 2012 Mar; 80(3):130-40. PubMed ID: 21611939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the use of stimulants and stimulant alternatives in treating bipolar depression and major depressive disorder.
    Corp SA; Gitlin MJ; Altshuler LL
    J Clin Psychiatry; 2014 Sep; 75(9):1010-8. PubMed ID: 25295426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Towards an understanding of the molecular mechanisms underlying the pharmacological treatments of attention deficit hyperactivity disorder].
    Castellanos FX; Acosta MT
    Rev Neurol; 2011 Mar; 52 Suppl 1():S155-60. PubMed ID: 21365598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulant therapy in attention deficit/hyperactivity disorder.
    Baldwin RL
    J Ark Med Soc; 2003 Dec; 100(6):203-6. PubMed ID: 14661403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic agents and stimulants as antidepressant augmentation strategies.
    Nierenberg AA; Dougherty D; Rosenbaum JF
    J Clin Psychiatry; 1998; 59 Suppl 5():60-3; discussion 64. PubMed ID: 9635549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulants for depression: On the up and up?
    Malhi GS; Byrow Y; Bassett D; Boyce P; Hopwood M; Lyndon W; Mulder R; Porter R; Singh A; Murray G
    Aust N Z J Psychiatry; 2016 Mar; 50(3):203-7. PubMed ID: 26906078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naturalistic long-term use of methylphenidate in bipolar disorder.
    Lydon E; El-Mallakh RS
    J Clin Psychopharmacol; 2006 Oct; 26(5):516-8. PubMed ID: 16974196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of attention-deficit-hyperactivity disorder.
    Elia J; Ambrosini PJ; Rapoport JL
    N Engl J Med; 1999 Mar; 340(10):780-8. PubMed ID: 10072414
    [No Abstract]   [Full Text] [Related]  

  • 15. Methylphenidate and depression.
    Ng B
    J Clin Psychopharmacol; 2008 Feb; 28(1):116-7; author reply 117-8. PubMed ID: 18204360
    [No Abstract]   [Full Text] [Related]  

  • 16. Alternative pharmacological strategies for adult ADHD treatment: a systematic review.
    Buoli M; Serati M; Cahn W
    Expert Rev Neurother; 2016; 16(2):131-44. PubMed ID: 26693882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update.
    Prince J
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S39-45. PubMed ID: 18480676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current evidence about atomoxetine. A therapeutic alternative for the treatment of attention deficit hyperactivity disorder].
    Velásquez-Tirado JD; Peña JA
    Rev Neurol; 2005 Oct 16-31; 41(8):493-500. PubMed ID: 16224736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropharmacological basis of stimulant drug action in attention deficit disorder with hyperactivity: a review and synthesis.
    Solanto MV
    Psychol Bull; 1984 May; 95(3):387-409. PubMed ID: 6152684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.